Skip to content

Fructose Rich Diet and Endothelial Function

Effects of Fructose Rich Diet Associated With Aerobic Training on Uric Acid Levels and Endothelial Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03939130
Enrollment
21
Registered
2019-05-06
Start date
2018-06-01
Completion date
2018-12-23
Last updated
2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aerobic Exercise, Fructose Metabolism Disorder, Fructose Rich Diet, Metabolic Disease

Brief summary

Cardiometabolic diseases have been associated with high consumption of sweetened beverages. These products are responsible for the largest portion of the total consumption of fructose in the diet and it is suggested that excessive intake of this monosaccharide may contribute to the development of risk factors for these diseases due to differences in metabolism relative to glucose. However, there is a lack of data in the literature demonstrating the deleterious effects of excessive fructose consumption on vasodilation and whether aerobic training may be able to prevent or mitigate these damages in humans. Therefore, the aim of the study will be to verify the effect of 4 weeks of high fructose diet associated with aerobic training on uric acid levels and its influence on markers related to oxidative stress and vasodilatation. Twenty-one sedentary men and women, aged between 19 and 35 years, will be submitted to 4 weeks of intervention. In a randomized way, subjects will be divided into 3 groups: high fructose diet, high glucose diet and high fructose diet and exercise. Blood samples will be taken before, in the middle and after the intervention to verify the concentrations of uric acid, superoxide dismutase enzyme, thiobarbituric acid, nitrite / nitrate, lipid profile, glucose, insulin, C-reactive protein and endothelin-1. In addition, flow-mediated dilatation, insulin resistance index, pancreatic beta cell functional capacity index, oral glucose tolerance test, 24-hour blood pressure, heart rate variability and body composition will be analyzed. The comparisons will be performed through the Generalized Estimates of Equations, adopting the factors group and time. The Bonferroni post-hoc will be used to identify differences. The accepted level of significance will be 5%.

Interventions

DIETARY_SUPPLEMENTFructose

Consumption of 1.0g / kg of body mass / day of fructose.

DIETARY_SUPPLEMENTGlucose

Consumption of 1.0g / kg of body mass / day of glucose.

OTHERFructose and exercise

Consumption of 1.0g / kg of body mass / day of fructose + 3 weekly sessions of 60 minutes of aerobic exercise.

Sponsors

Federal University of Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women; * Not engaged in regular exercises; * Aged between 19 and 35 years; * Body mass index (BMI) of less than 30kg / m².

Exclusion criteria

* Individuals with BMI below 18kg / m² and greater than 30kg / m²; * Smokers; * Dyslipidemic; * Diabetic; * Hypertensive; * Alcohol use; * Appetite suppressants use; * Medications use; * Supplements use; * Chronic disease that impedes the performance of physical exercise.

Design outcomes

Primary

MeasureTime frame
Flow Mediated Dilatation4 weeks
Concentration of Uric Acid4 weeks
Concentration of Nitrite / Nitrate4 weeks

Secondary

MeasureTime frameDescription
Concentration of Triglycerides4 weeks
Concentration of Low-Density Lipoprotein4 weeks
Concentration of High-Density Lipoprotein4 weeks
Concentration of Glucose4 weeks
Concentration of Insulin4 weeks
HOMA-IR4 weeks
Concentration of Superoxide Dismutase Enzyme4 weeks
Insulin Sensitivity4 weeksOral glucose tolerance test
Concentration of C-Reactive Protein4 weeks
Concentration of Endothelin-14 weeks
24-hour Blood Pressure4 weeks
Heart Rate Variability4 weeks
Body Fat4 weeks
HOMA-B4 weeks
Concentration of Substances Reactive to Thiobarbituric Acid4 weeksOxidative stress outcome
Concentration of Total Cholesterol4 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026